Latest News

Findings reveal an obvious area for improvement in population health.
The report on the Traditional Foods Project is part of CDC supplement on reducing healthcare disparities.
A study published in JAMA Oncology found that the knowledge of genetic risk influenced surgical treatment decisions in women younger than 40 years who were diagnosed with breast cancer.
What we're reading, February 11, 2016: Plaintiffs lose their case against cigarette manufacturer; the politics behind providing care for those infected with Zika; and of course, prescription drug prices.
While there are no significant differences in the results between filgrastim and TBO-filgrastim in a clinical setting, TBO-filgrastim offers significant cost savings over filgrastim.
Seven of the states with the largest reductions in uninsured rates since the implementation of the Affordable Care Act have both expanded Medicaid and established a state-based exchange or a state-federal partnership.
Using surgery to promote weight loss and improve health is associated with improve mortality. This study sought information on whether survival benefits extended to patients at higher ages.
Dr Georges Benjamin Discusses the Importance of Diversity in Healthcare
A lack of diversity among healthcare providers can adverse effects for the communities they serve, explained Georges Benjamin, MD, executive director of the American Public Health Association.
The study, while small, suggests a scalable solution that would allow payers address diabetes prevention and health disparities.
Mice administered FOLFIRINOX through the implantable device had greater tumor regression and lower tissue toxicity.
What we're reading, February 10, 2016: 2 companies change how consumers purchase medicines online; CMS memo reveals the government is mulling changes to Medicare reimbursement; and Johns Hopkins will transplant HIV-positive organs to HIV-positive recipients.
As physicians and researchers question whether certain treatments for early signs of breast cancer are necessary, the first large US study will seek to determine the best way to manage ductal carcinoma in situ.
Innovation has remained high on the administration’s agenda, as is evident from the allocations to tackle climate changes as well as find treatments for devastating health conditions.
CMS has already delayed Medicaid managed care once, pushing the start date back to at least March 1, 2016.

From the Journals

At the annual JP Morgan Healthcare Conference, Patrick Soon-Shiong, MD, introduced Cancer MoonShot, his vision for a coalition to improve cancer outcomes. His claims on federal support for the project, however, stirred some controversy.
While the number and diversity of immunologically-based anticancer agents have increased dramatically, a number of challenging questions persist: sequencing with existing regimens, selection of best responders, cost, and patient access.
The cost issues with immuno-oncology agents are real, but so is the value that they bring to the table. How can we improve access to these agents at a reasonable cost?
An overview of patient assistance programs at Smilow Cancer Hospital at Yale-New Haven, including their innovative hospital-based explanation of benefits form, which can eliminate patient responsibilities and help expedite the turnaround times for payment processing with copay assistance.
Ensuring rapid, appropriate, and sustainable access to immuno-oncology therapies for patients in Europe: what role can policies play?
To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Advances made in the field of immuno-oncology (I-O) in 2015 have greatly expanded our understanding of I-O and added more complexity to its value assessment.
Supporting, funding, and protecting the research and development of new medicines and new treatments is more critical, now than ever, to provide better treatments and better outcomes to all cancer patients.
Re-analysis of US Preventive Services Task Force colorectal cancer screening guidelines shows that every-3-year screening with multi-target sDNA could address poor performance of recommended annual testing.
Featured Content
Diabetes Compendium
Oncology Compendium
COPD Compendium
Reimbursement Compendium

Most Popular

AJMC Strategic Alliance